Cite
Cervera-Carrascon V, Quixabeira DCA, Havunen R, et al. Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors. Mol Ther Oncolytics. 2020;17:47-60doi: 10.1016/j.omto.2020.03.003.
Cervera-Carrascon, V., Quixabeira, D. C. A., Havunen, R., Santos, J. M., Kutvonen, E., Clubb, J. H. A., Siurala, M., Heiniö, C., Zafar, S., Koivula, T., Lumen, D., Vaha, M., Garcia-Horsman, A., Airaksinen, A. J., Sorsa, S., Anttila, M., Hukkanen, V., Kanerva, A., & Hemminki, A. (2020). Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors. Molecular therapy oncolytics, 1747-60. https://doi.org/10.1016/j.omto.2020.03.003
Cervera-Carrascon, Victor, et al. "Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors." Molecular therapy oncolytics vol. 17 (2020): 47-60. doi: https://doi.org/10.1016/j.omto.2020.03.003
Cervera-Carrascon V, Quixabeira DCA, Havunen R, Santos JM, Kutvonen E, Clubb JHA, Siurala M, Heiniö C, Zafar S, Koivula T, Lumen D, Vaha M, Garcia-Horsman A, Airaksinen AJ, Sorsa S, Anttila M, Hukkanen V, Kanerva A, Hemminki A. Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors. Mol Ther Oncolytics. 2020 Mar 19;17:47-60. doi: 10.1016/j.omto.2020.03.003. eCollection 2020 Jun 26. PMID: 32322662; PMCID: PMC7163046.
Copy
Download .nbib